Drug-related mortality and its impact on adult mortality in eight European countries

A. M. BARGAGLI ; M. HICKMAN ; M. DAVOLI ; C. A. PERUCCI ; P. SCHIFANO ; M. BUSTER ; T. BRUGAL ; J. VICENTE | 2006
Dans European Journal of Public Health (Vol.16, n°2, April 2006) Article : Périodique

ENGLISH : Objective: To estimate the mortality rates from drug-related deaths and other causes among problem drug users and population attributable risk of death due to opiate use in eight study sites in Europe. Methods: Opiate users were recr[...]

Plus d'info

Ajouter à la sélection

Mortality among drug users in Europe: new and old challenges for public health

OEDT = EMCDDA ; I. GIRAUDON ; M. BUSTER ; A. ESPELT ; J. MATIAS ; J. VICENTE | 2015
Rapport

This paper examines the overall number of lives lost due to drug use. All-cause mortality among problem drug users is investigated by means of cohort studies, which link data from death registries to drug treatment records. Building on earlier w[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Mortality among drug users in Europe: a project of the European Monitoring Centre for Drugs and Drug Addiction

A. M. BARGAGLI ; SPERATI A. ; M. DAVOLI ; C. PERUCCI ; J. VICENTE ; R. HARTNOLL ; J. BARRY ; T. BRUGAL ; M. BUSTER ; F. FERRAZ DE OLIVEIRA ; HAASTRUP L. ; A. HEINEMANN ; KOUKLINOS A. ; D. RISSER ; SVENSSON D. ; VUORI E. | 2002
Périodique

ENGLISH : The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is currently coordinating a project which aims to enrol and follow up prospective cohorts of problem drug users (PDUs) in several countries, so as to compare overal[...]

Plus d'info

Ajouter à la sélection

Prevention and reduction of health-related harm associated with drug dependence. An inventory of policies, evidence and practices in the EU relevant to the implementation of the Council Recommendation of 18 June 2003. Synthesis report

D. VAN DER GOUWE ; M. GALLA ; A. VAN GAGELDONK ; E. CROES ; J. ENGELHARDT ; M. VAN LAAR ; M. BUSTER | 2006
Rapport

FRANÇAIS : Buts et objectifs : Suite à un appel d'offres ouvert, la Commission européenne a décidé d'engager les services de l'Institut Trimbos pour collecter et analyser les informations de base d'un rapport de la Commission conformément au P[...]

Plus d'info

Ajouter à la sélection

Lien externe

The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam

A. MATSER ; A. URBANUS ; R. B. GESKUS ; M. KRETZSCHMAR ; M. XIRIDOU ; M. BUSTER ; R. COUTINHO ; M. PRINS | 2012
Dans Addiction (Vol.107, n°3, March 2012) Article : Périodique

AIMS: The hepatitis C virus (HCV) disease burden among injecting drug users (IDUs) is determined by HCV incidence, the long latency period of HCV, competing mortality causes, presence of co-infection and HCV treatment uptake. We examined the eff[...]

Plus d'info

Ajouter à la sélection

Lien externe